immune disorders
X Linked Lymphoproliferative Syndrome
Treatment of X Linked Lymphoproliferative Syndrome
Stem cell transplantation About 80% of people who receive a Stem Cell Transplantation survive. But without transplantation, three quarters of people die before age 10 years, and all die by age 40. Transplantation can cure X-linked lymphoproliferative syndrome if it is done before EBV infection or other disorders become too severe. Rituximab(a drug that modifies the immune system's activity) can help prevent severe EBV infection before transplantation is done. 